CardioLogs ECG Analysis Platform vs FibriCheck
AI Verdict
Choose CardioLogs ECG Analysis Platform if…
Choose CardioLogs ECG Analysis Platform if your clinical practice requires a robust, AI-powered solution for the rapid and accurate analysis of ECG data from a wide range of cardiac monitoring devices. This platform is ideal for healthcare providers seeking to streamline arrhythmia detection, integrate seamlessly with existing EHR systems, and manage high volumes of ECGs efficiently.
View CardioLogs ECG Analysis Platform →Choose FibriCheck if…
Choose FibriCheck if you are a patient looking for a convenient, smartphone-based solution to regularly monitor your heart rhythm for arrhythmias, or if you are a healthcare provider seeking to empower patients with an accessible remote monitoring tool. This app is best suited for ongoing patient self-monitoring with immediate results, offering an optional professional review for anomalous measurements.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CardioLogs ECG Analysis Platform | FibriCheck |
|---|---|---|
| Pricing | Unknown | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Cloud-based | Cloud-based (private cloud). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck offers a highly accessible patient-facing mobile application that allows users to monitor their heart rhythm using just a smartphone camera, making it very user-friendly for a broad audience. While CardioLogs provides efficient tools for clinicians to analyze complex ECG data, FibriCheck's direct patient engagement and simplicity for self-monitoring give it an edge in overall usability.
Clinical Value
CardioLogs ECG Analysis PlatformCardioLogs leverages deep neural networks trained on over 200 million ECG recordings for comprehensive and accurate analysis of ECG data from various medical-grade devices, including Holter monitors. It was the first AI solution approved by the FDA for ECG analysis in 2017 and has demonstrated superior performance over consumer wearables in detecting atrial arrhythmias. While FibriCheck is medically certified and clinically validated for smartphone-based PPG, CardioLogs offers a deeper diagnostic capability by analyzing more comprehensive ECG data.
Pricing & Value
FibriCheckFibriCheck provides transparent, tiered pricing for end-users, including monthly/yearly subscriptions and short-term options for doctor-prescribed use, making its cost and value proposition clear. CardioLogs requires contacting sales for a customized quote, which lacks the immediate transparency and direct comparison capability of FibriCheck's published pricing structure.
Enterprise Readiness
CardioLogs ECG Analysis PlatformCardioLogs, now a Philips solution, benefits from the robust infrastructure, established sales channels, and trust associated with a major healthcare technology company. Its explicit mention of EHR system integration and ISO/IEC 27001 certified AWS servers demonstrates a strong foundation for large-scale enterprise deployments. FibriCheck, while HIPAA compliant and offering a professional portal, does not detail the same level of enterprise backing or infrastructure specifics.
Innovation
CardioLogs ECG Analysis PlatformCardioLogs showcases significant innovation through its deep neural network technology, trained on an extensive database of over 200 million ECGs, for comprehensive analysis across diverse medical devices. It was also the first AI solution approved by the FDA for ECG analysis in 2017, marking a pioneering achievement in the field. While FibriCheck's smartphone camera-based PPG is innovative for patient accessibility, CardioLogs demonstrates a more profound technological advancement in diagnostic AI.
Support & Docs
FibriCheckFibriCheck offers extensive developer documentation, including SDKs and APIs for integration, alongside a comprehensive Help Center with user manuals and FAQs for both patients and healthcare providers. It also provides direct contact options for support via email and phone. CardioLogs offers technical support and documentation, but FibriCheck's resources appear more detailed and readily available for a broader range of users and integration needs.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CardioLogs ECG Analysis Platform | FibriCheck |
|---|---|---|
| Primary Use Case | Uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. | Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Company | Cardiologs Technologies (now part of Philips) | Qompium nv |
| Core Technology | AI-Powered ECG Analysis (Deep Neural Networks) | Smartphone camera-based PPG technology for heart rhythm measurement; AI-powered algorithm for arrhythmia detection and analysis. |
| Supported Monitoring Devices | Multi-Device Compatibility (Holter, smartwatches, ECG patches) | Smartphone camera |
| Target User Group | Physicians | Patients (end-users) and Healthcare Providers (via portal/dashboard) |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and FibriCheck.